Both in Pharmaceuticals
Alzamend Neuro vs Enveric Biosciences
Over the past year ALZN returned −50.8% and ENVB returned −79.5%; their daily moves had a correlation of 0.02.
ALZN −50.8% ENVB −79.5%Growth of $1, one year, split-adjusted
| Metric | ALZN | ENVB |
|---|---|---|
| Price | $1.25 | $1.45 |
| Market cap | $6.0M | $6.5M |
| Today | +3.31% | +1.40% |
| 1 month | −8.8% | −2.0% |
| 6 months | +12.6% | −57.5% |
| Year to date | −31.3% | −60.1% |
| 1 year | −52.1% | −76.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.6M | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | 77.2% | 48.0% |
| Short % of float | 0.7% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).